Corina R Zisman1, Marisa A Patti2, Luther G Kalb3, Emma K Stapp4, Kathryn Van Eck5, Heather Volk6, Calliope Holingue3. 1. Section on the Neurobiology of Fear and Anxiety, National Institute of Mental Health, 9000 Rockville Pike, Bethesda, MD, 20892, United States. Electronic address: corinazisman@gmail.com. 2. Department of Epidemiology, Brown University School of Public Health, 121 S Main St, Providence, RI 02903, United States. 3. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway, Baltimore, MD, 21205, United States; Wendy Klag Center for Autism and Developmental Disabilities, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, United States; Department of Neuropsychology, Kennedy Krieger Institute, 1750 E Fairmount Ave, Baltimore, MD, 21231, United States. 4. Genetic Epidemiology Branch, Intramural Research Program, National Institute of Mental Health, 35 Convent Drive MSC 3720, Bldg. 35A, Bethesda, MD 20892-3720, United States. 5. Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, 1800 Orleans Street, Baltimore, MD 21287, United States; Department of Psychiatry, Kennedy Krieger Institute, 1741 Ashland Ave, Baltimore, MD, 21205, United States. 6. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway, Baltimore, MD, 21205, United States; Wendy Klag Center for Autism and Developmental Disabilities, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Abstract
OBJECTIVE: The primary aim of this study was to evaluate differences in the prevalence of complementary and alternative medicine (CAM) usage among children with and without developmental disabilities (DD). Secondarily, the association between CAM usage and comorbid chronic medical conditions was explored among children with DD. DESIGN: Data come from the 2012 Child Complementary and Alternative Medicine Supplement of the National Health Interview Survey, a nationally representative sample of children in the United States between the ages of 4 and 17 (n = 10,218).Main outcome measures Multiple logistical regression models provided insight into the relationships between parent-report CAM usage, DD, and chronic medical conditions. RESULTS: Children with developmental disabilities were more likely to use CAMs compared to their typically developing peers (21% vs 16%). Children with DDs and comorbid chronic medical conditions used CAMs at even higher rates (23% vs 18%). CONCLUSIONS: Results indicated that children with DD, especially those with a co-occurring chronic medical condition, use CAMs more often that typically developing children. Given scarcity of information on safety and effectiveness, clinical providers need to be alert to which children may be more likely to be exposed to CAMs. Communication between parents and providers needs to include discussion of CAM treatments. Published by Elsevier Ltd.
OBJECTIVE: The primary aim of this study was to evaluate differences in the prevalence of complementary and alternative medicine (CAM) usage among children with and without developmental disabilities (DD). Secondarily, the association between CAM usage and comorbid chronic medical conditions was explored among children with DD. DESIGN: Data come from the 2012 Child Complementary and Alternative Medicine Supplement of the National Health Interview Survey, a nationally representative sample of children in the United States between the ages of 4 and 17 (n = 10,218).Main outcome measures Multiple logistical regression models provided insight into the relationships between parent-report CAM usage, DD, and chronic medical conditions. RESULTS: Children with developmental disabilities were more likely to use CAMs compared to their typically developing peers (21% vs 16%). Children with DDs and comorbid chronic medical conditions used CAMs at even higher rates (23% vs 18%). CONCLUSIONS: Results indicated that children with DD, especially those with a co-occurring chronic medical condition, use CAMs more often that typically developing children. Given scarcity of information on safety and effectiveness, clinical providers need to be alert to which children may be more likely to be exposed to CAMs. Communication between parents and providers needs to include discussion of CAM treatments. Published by Elsevier Ltd.
Entities:
Keywords:
Alternative Medicine; Autism Spectrum Disorder; Comorbid Medical Conditions; Developmental Disabilities
Authors: Coleen A Boyle; Sheree Boulet; Laura A Schieve; Robin A Cohen; Stephen J Blumberg; Marshalyn Yeargin-Allsopp; Susanna Visser; Michael D Kogan Journal: Pediatrics Date: 2011-05-23 Impact factor: 7.124
Authors: Mayilee Canizares; Sheilah Hogg-Johnson; Monique A M Gignac; Richard H Glazier; Elizabeth M Badley Journal: PLoS One Date: 2017-05-11 Impact factor: 3.240